Warning letter

Advocate Health Care: warning letter of Jun 1, 2012

FDA warning letter 289899 · Center for Drug Evaluation and Research

Key facts

Reference number 289899
Company Advocate Health Care
Subject Institutional Review Board (IRB)
Issue date Jun 1, 2012
Posted date Jun 1, 2012
Issuing office Center for Drug Evaluation and Research
Product type Drugs
CFR sections cited 56, 56.111(a)(4), 56.111, 50.24, 50
Inspection city Downers Grove
Inspection ZIP 60515
Inspection start date Nov 7, 2011
Letter on fda.gov web.archive.org

At a glance

  • 1–9 CFR sections cited
  • OAI Linked inspection classification
  • Yes Form FDA 483 issued

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA warning letters

FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.

Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date:

Browse all FDA warning letters